Implementation Framework for the ISHLT Statement on Transplant Ethics
Published 23 July 2026
The Ethics Committee has developed a principles-based ISHLT Statement on Transplant Ethics that articulates the Society’s core ethical values while intentionally avoiding case-specific rules or operational guidance. A separate implementation framework determined by the Board of Directors guides the application of those principles to ISHLT programs, beginning with scientific abstracts submitted for the 2027 Annual Meeting.
The purpose of this implementation framework is not to certify the ethical practices of any jurisdiction or institution, but rather to determine whether ISHLT has sufficient confidence that a scientific submission is consistent with the Society's ethical principles to warrant presentation under the ISHLT name.
Read at JHLTRelated Guidlines
-
The 2015 ISHLT Guidelines for the Management of Fungal Infections in Mechanical Circulatory Support and Cardiothoracic Organ Transplant Recipients: Executive Summary
-
Report from a Consensus Conference on Primary Graft Dysfunction after Cardiac Transplantation
-
Donor Heart and Lung Procurement: A Consensus Statement
-
2009 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
-
A 2010 Working Formulation for the Standardization of Definitions of Infections in Cardiothoracic Transplant Recipients

